WeVote
Log In

Bill

Bill

HB 1433

Concerning access to psychedelic substances.

2025-2026 Regular Session Introduced by Adam Bernbaum and 27 co-sponsors

Washington HB 1433 proposes expanding access to psychedelic substances, pending committee review of specific therapeutic, decriminalization, or research provisions.

By resolution, reintroduced and retained in present status.
0
WeVote Research Nonpartisan
Bill Summary · HB 1433

Legislative bill overview

HB 1433 addresses access to psychedelic substances in Washington state, though specific provisions are not yet publicly detailed given its early legislative stage. The bill has been referred to the House Committee on Health Care & Wellness, indicating it will examine regulatory, therapeutic, or decriminalization frameworks for these substances. A public hearing is scheduled for February 5, 2025, where the bill's specific language and intent will be formally discussed.

Why this is important

Psychedelic substances remain federally controlled, but several states and jurisdictions have begun exploring therapeutic applications (particularly psilocybin for treatment-resistant conditions) or decriminalization models. Washington's consideration reflects growing scientific interest in psychedelic-assisted therapy and broader drug policy reform discussions that could affect healthcare access, criminal justice, and research opportunities in the state.

Potential points of contention

  • Federal-state legal conflict: Psychedelics remain Schedule I substances federally, creating tension between state authorization and federal law enforcement priorities
  • Medical safety and liability: Determining appropriate clinical oversight, dosing, screening, and provider qualifications for therapeutic use versus recreational access
  • Implementation scope: Whether the bill addresses decriminalization, licensed therapeutic access, research expansion, or some combination—each carries different public health and regulatory implications

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.